| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485436 | Vaccine | 2018 | 7 Pages |
Abstract
Single dose 9vHPV vaccination is projected to avert substantial CC burden in South Africa and similar high HIV prevalence settings. Health benefits were comparable across all female subpopulations stratified by HIV status, CD4 count, and ART status.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Nicholas Tan, Monisha Sharma, Rachel Winer, Denise Galloway, Helen Rees, Ruanne V. Barnabas,